- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MSOS
Recent news which mentions MSOS
From MarketWatch
3 High-Growth ETFs That Can Set You Up for Life
April 23, 2022
From Motley Fool
Real estate ETFs see these types of properties holding up in ‘tricky’ time for investing
April 21, 2022
From MarketWatch
Leafly CEO rings Nasdaq bell on cannabis holiday
April 20, 2022
From MarketWatch
From ETF Trends
From InvestorPlace
3 Top Cannabis Stocks to Buy for April
April 17, 2022
From Motley Fool
Urban-gro eyes 80% revenue growth as indoor farm specialist
April 11, 2022
From MarketWatch
From MarketWatch
From MarketWatch
Trulieve says revenue guidance that lags Wall Street estimate is realistic; ‘It’s very solid,’ says CEO
March 31, 2022
Tickers
MSOS
Tags
MSOS
From MarketWatch
Cannabis company that DEA is allowing to grow for research purposes to list shares on Nasdaq
March 29, 2022
From MarketWatch
2 Cannabis Stocks That Could Make You Richer
March 27, 2022
From Motley Fool
From MarketWatch
Cresco Labs buying Columbia Care in major cannabis merger
March 23, 2022
From MarketWatch
From MarketWatch
Cannabis company Akanda’s stock rockets in trading debut
March 15, 2022
From MarketWatch
Curaleaf narrows quarterly loss and tops $1 billion in annual revenue for the first time
March 04, 2022
From MarketWatch
From MarketWatch
2 Unstoppable Long-Term Trends to Invest In
March 03, 2022
From Motley Fool
From MarketWatch
Curaleaf moves to quash rumors that executives’ ties to Russia may lead to sanctions
February 28, 2022
From MarketWatch
From Benzinga
The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More
February 11, 2022
From Benzinga
Chart: Is Cannabis Debt Priced Accurately? This Unique Credit Tracker Has The Answer
February 08, 2022
From Benzinga
Senate Democrats face two possible avenues for cannabis legislation
February 08, 2022
From MarketWatch
The Week In Cannabis: House Approves Banking Bill, Stocks Surge, Mississippi Legalizes Medical, M&A, Hexo's Troubles And More
February 04, 2022
From Benzinga
Why Tilray’s Name Change Makes Total Sense
February 02, 2022
From InvestorPlace
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.